HIV trials recruiting in Georgia

All HIV trials nationally

Cities in Georgia

Recruiting trials in Georgia

• A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
  NCT07266831 · Phase: Phase 2, Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Decatur, Macon
• A Clinical Study of MK-8527 to Prevent Human Immunodeficiency Virus Type 1 (HIV-1) (MK-8527-011)
  NCT07044297 · Phase: Phase 3 · Ages: 16 Years and older · Sex: All (male and female) · Georgia: Decatur
• A Clinical Trial of Combination HIV-Specific Broadly Neutralizing Monoclonal Antibodies Combined With ART Initiation During Acute HIV Infection to Induce HIV Remission
  NCT05719441 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: All (male and female) · Georgia: Atlanta
• A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
  NCT07202546 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Macon
• A Study of Safety and Drug Levels of ePGT121v1-LS, PGDM1400LS, and VRC07-523LS in Adult Participants Without HIV-1
  NCT07390955 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Georgia: Atlanta
• A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
  NCT07650916 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Georgia: Decatur
• A Trial to Evaluate the Safety and Tolerability of DV700P-RNA and DV701B1.1-RNA Immunization in Combination With Antiretroviral Analytical Treatment Interruption (ATI) in People Living With HIV for Elicitation of V3-glycan Antibodies
  NCT07569029 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Georgia: Atlanta, Decatur
• Baricitinib for Reduction of HIV - CNS
  NCT05452564 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Georgia: Atlanta
• Clinical Trial to Evaluate the Safety and Immunogenicity of Hiltonol, Poly-ICLC-adjuvanted CD40.HIVRI.Env (VRIPRO) in Adult Participants Who Previously Participated in HVTN 706
  NCT06665646 · Phase: Phase 1 · Ages: 18 Years to 60 Years · Sex: All (male and female) · Georgia: Decatur
• Clinical Trial to Evaluate the Safety and Immunogenicity of a Priming Regimen of 426c.Mod.Core-C4b Followed by HxB2.WT.Core-C4b Boosts, Both Adjuvanted With 3M-052 AF + Alum, in Adult Participants Without HIV and in Overall Good Health
  NCT06796686 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Georgia: Atlanta, Decatur
• Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV
  NCT07390474 · Phase: Phase 1 · Ages: 18 Years to 55 Years · Sex: All (male and female) · Georgia: Atlanta, Decatur
• Doravirine (DOR) in Human Immunodeficiency Virus (HIV)-Infected Children Aged 4 Weeks to <12 Years and <45 kg (MK-1439-066)
  NCT04375800 · Phase: Phase 2 · Ages: 4 Weeks to 11 Years · Sex: All (male and female) · Georgia: Atlanta
• Evaluation of Safety, Immunogenicity and Efficacy of a Triple Immune Regimen in Adults Initiated on ART During Acute HIV-1
  NCT06071767 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• HIV Treatment Adherence Dose Determination Trial
  NCT04577313 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
  NCT07473778 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Inflammation and Depression in People With HIV
  NCT05849038 · Phase: Phase 2 · Ages: 18 Years to 65 Years · Sex: All (male and female) · Georgia: Atlanta
• Low Dose Naltrexone for Pain in Patients With HIV
  NCT05537935 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · Georgia: Atlanta
• Menopausal HT for Women Living With HIV (HoT)
  NCT06856174 · Phase: Phase 4 · Ages: 40 Years to 60 Years · Sex: Female · Georgia: Atlanta
• Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
  NCT07040592 · Phase: Phase 2 · Ages: 18 Years to 99 Years · Sex: All (male and female) · Georgia: Decatur
• Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
  NCT05674656 · Phase: Phase 1, Phase 2 · Ages: 6 Years to 12 Years · Sex: All (male and female) · Georgia: Atlanta
• Safety of Anal Curcumin
  NCT06626230 · Phase: Phase 1 · Ages: 30 Years and older · Sex: All (male and female) · Georgia: Atlanta
• Screen2Prevent (S2P)
  NCT07728123 · Phase: Not applicable (e.g. observational or device study) · Ages: 14 Years to 24 Years · Sex: All (male and female) · Georgia: Atlanta
• Screening Strategies Among High-risk Populations for Anal Cancer
  NCT06628570 · Phase: Not applicable (e.g. observational or device study) · Ages: 30 Years to 80 Years · Sex: All (male and female) · Georgia: Atlanta
• Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy
  NCT07682961 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · Georgia: Atlanta, Savannah
• Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United States
  NCT07293559 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Georgia: Atlanta
• Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
  NCT02140255 · Phase: Phase 1, Phase 2 · Ages: Up to 48 Hours · Sex: All (male and female) · Georgia: Atlanta